BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28122026)

  • 1. Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway.
    Wang A; Li T; An P; Yan W; Zheng H; Wang B; Mu Y
    PLoS One; 2017; 12(1):e0169469. PubMed ID: 28122026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1.
    Xu F; Lin B; Zheng X; Chen Z; Cao H; Xu H; Liang H; Weng J
    Diabetologia; 2016 May; 59(5):1059-69. PubMed ID: 26924394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes.
    Góralska J; Śliwa A; Gruca A; Raźny U; Chojnacka M; Polus A; Solnica B; Malczewska-Malec M
    Acta Biochim Pol; 2017; 64(3):423-429. PubMed ID: 28822994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression.
    Kim Chung le T; Hosaka T; Yoshida M; Harada N; Sakaue H; Sakai T; Nakaya Y
    Biochem Biophys Res Commun; 2009 Dec; 390(3):613-8. PubMed ID: 19850014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling.
    Pastel E; Joshi S; Knight B; Liversedge N; Ward R; Kos K
    Nutr Diabetes; 2016 Dec; 6(12):e235. PubMed ID: 27941938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1.
    Chen S; Zhao Z; Ke L; Li Z; Li W; Zhang Z; Zhou Y; Feng X; Zhu W
    J Nutr Biochem; 2018 May; 55():209-218. PubMed ID: 29554499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice.
    Kooijman S; Wang Y; Parlevliet ET; Boon MR; Edelschaap D; Snaterse G; Pijl H; Romijn JA; Rensen PC
    Diabetologia; 2015 Nov; 58(11):2637-46. PubMed ID: 26254578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
    Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
    Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.
    Nie ZJ; Zhang YG; Chang YH; Li QY; Zhang YL
    Biomed Pharmacother; 2018 Oct; 106():1364-1369. PubMed ID: 30119208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fisetin up-regulates the expression of adiponectin in 3T3-L1 adipocytes via the activation of silent mating type information regulation 2 homologue 1 (SIRT1)-deacetylase and peroxisome proliferator-activated receptors (PPARs).
    Jin T; Kim OY; Shin MJ; Choi EY; Lee SS; Han YS; Chung JH
    J Agric Food Chem; 2014 Oct; 62(43):10468-74. PubMed ID: 25286082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes.
    Montrose-Rafizadeh C; Yang H; Wang Y; Roth J; Montrose MH; Adams LG
    J Cell Physiol; 1997 Sep; 172(3):275-83. PubMed ID: 9284947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 Protects Against Myocardial Ischemia-Reperfusion Injury by Upregulation of SIRT1 and SIRT3 and Activation of AMPK.
    Eid RA; Bin-Meferij MM; El-Kott AF; Eleawa SM; Zaki MSA; Al-Shraim M; El-Sayed F; Eldeen MA; Alkhateeb MA; Alharbi SA; Aldera H; Khalil MA
    J Cardiovasc Transl Res; 2021 Aug; 14(4):619-635. PubMed ID: 32239434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect effects of glucagon-like peptide-1 receptor agonist exendin-4 on the peripheral circadian clocks in mice.
    Ando H; Ushijima K; Fujimura A
    PLoS One; 2013; 8(11):e81119. PubMed ID: 24260546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice.
    Lee J; Hong SW; Chae SW; Kim DH; Choi JH; Bae JC; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Lee WY
    PLoS One; 2012; 7(2):e31394. PubMed ID: 22363635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLP-1 receptor agonist increases the expression of CTRP3, a novel adipokine, in 3T3-L1 adipocytes through PKA signal pathway.
    Li X; Jiang L; Yang M; Wu Y; Sun S; Sun J
    J Endocrinol Invest; 2015 Jan; 38(1):73-9. PubMed ID: 25149084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats.
    Barakat G; Moustafa ME; Khalifeh I; Hodroj MH; Bikhazi A; Rizk S
    J Physiol Biochem; 2016 Aug; 73(3):387-394. PubMed ID: 28589533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory switch from Gαs to Gαi signaling by Glucagon-like peptide-1 receptor in murine splenic monocyte following burn injury.
    Zhang QH; Hao JW; Li GL; Ji XJ; Yao XD; Dong N; Yao YM
    Inflamm Res; 2018 Feb; 67(2):157-168. PubMed ID: 29022064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of metabolic memory-induced neurodegeneration and the therapeutic effects of glucagon-like peptide-1 receptor agonists via Forkhead box class O.
    Chen S; Tang Q; Wang Y; Xu Z; Chen ST; Sun Y; Yao WB; Gao XD
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):371-377. PubMed ID: 30465895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of GLP-1R improved the dysfunction of late EPCs under hyperglycemia by regulating SIRT1 expression.
    Tu Q; Wang JF; Xie HQ; Zhao Q; Fu J; Xu HL; Cao Z
    Mol Cell Endocrinol; 2021 Dec; 538():111455. PubMed ID: 34509564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.